We are live on ! Find out more

14 hedge funds and large institutions have $7.45M invested in BioVie in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

8% more funds holding

Funds holding: 1314 (+1)

0.01% more ownership

Funds ownership: 0.06%0.07% (+0.01%)

25% less capital invested

Capital invested by funds: $9.96M → $7.45M (-$2.51M)

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
7
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Sabby Management
Florida
$2.92M +$828K +1,433 +28%
KC
2
Kepos Capital
New York
$2.81M
Vanguard Group
3
Vanguard Group
Pennsylvania
$740K
S
4
swisspartners
Liechtenstein
$367K
Geode Capital Management
5
Geode Capital Management
Massachusetts
$127K +$54.3K +94 +49%
SC
6
Shay Capital
New York
$106K +$4.04K +7 +3%
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
$106K +$136K +235 New
LFCM
8
Long Focus Capital Management
Puerto Rico
$90K +$116K +200 New
State Street
9
State Street
Massachusetts
$67K +$85.5K +148 New
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$48K +$61.2K +106 New
BlackRock
11
BlackRock
New York
$45K +$20.8K +36 +56%
UBS Group
12
UBS Group
Switzerland
$10K +$11.6K +20 +2,000%
Morgan Stanley
13
Morgan Stanley
New York
$7K +$8.09K +14 +1,400%
Osaic Holdings
14
Osaic Holdings
Arizona
$5K +$1.73K +3 +43%
Renaissance Technologies
15
Renaissance Technologies
New York
-$355K -531 Closed
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
-$71K -106 Closed
Bank of America
17
Bank of America
North Carolina
-$7K -11 Closed

BIVI Hedge Fund Activity: Q4 2021 in Review

14 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q4 2021, worth a combined $7.45M — down 25% from $9.96M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BIVI positions and 3 closed out — a net gain of 1 holder — while 7 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, adding an estimated $828K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $355K sold.

  • 14 institutional investors held BioVie (BIVI) as of Q4 2021, up from 13 in Q3 2021.
  • Funds reported $7.45M of BioVie stock for Q4 2021, down 25% quarter-over-quarter.
  • 4 funds opened new BioVie positions in Q4 2021 and 3 closed out, a net change of +1 holder.
  • The largest BioVie buyer in Q4 2021 was Sabby Management, an estimated $828K added.
  • The largest BioVie seller in Q4 2021 was Renaissance Technologies, an estimated $355K sold.

Based on aggregated 13F filings for Q4 2021.